top of page
84770f_68a07779fe514e93b3876e8ff37f34c4~mv2_edited.png

ASX:UBI

Universal Biosensors, Inc.

Investment Summary

The fund managers believe that Universal Biosensors, Inc. (UBI) is positioned for growth following its announcement of a fully underwritten $10 million capital raise at $0.15 per share. In their opinion, the funds will be effectively utilized for crucial pipeline activities, sales and marketing, research and development, and general working capital purposes. This strategic move is anticipated to enhance the company’s operational capabilities and drive future performance.

feedback.png

Commentary From The Managers

Endeavor Asset Management

30 Apr 2024

$0.15

  • Endeavor Asset Management updates their investment thesis on Universal Biosensors (UBI).
  • UBI announced a fully underwritten $10 million capital raise at $0.15 per share.
  • Proceeds will be allocated to pipeline activities, as well as sales and marketing.
  • Funds will also support research and development activities and general working capital purposes.
  • Endeavor Asset Management continues to hold their position in UBI due to these strategic investments.

Please note: The completeness, accuracy or current status of the investments referenced are not guaranteed. 

Subscribe

Join the email list for updates.

Thanks for submitting!

Thesis-Tracker.com aggregates insights from financial services professionals exclusively for informational and educational purposes. Thesis-Tracker.com does not publish proprietary opinions nor does Thesis-Tracker.com enter into commercial arrangements with any of the featured financial services professionals. Before making a decision please consider these and any relevant Product Disclosure Statement. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs.

bottom of page